Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print June 2, 2008
DOI: 10.2337/db07-0981

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0981v1
57/9/2393    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johansson, U.
Right arrow Articles by Magnusson, P.U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johansson, U.
Right arrow Articles by Magnusson, P.U.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Formation of Composite Endothelial Cell-Mesenchymal Stem Cell-Islets; a novel approach to promote islet revascularization

U. Johansson1, I. Rasmusson1, S.P. Niclou2, N. Forslund1, L. Gustavsson1, B. Nilsson1, O. Korsgren1, and P.U. Magnusson1

1Division of Clinical Immunology, The Rudbeck Laboratory, C11, SE-751 85 UPPSALA, Sweden
2CRP-Santé, NorLux Neuro-Oncology Laboratory, 84, Val Fleuri, L-1526 Luxembourg

Objective: Mesenchymal stem cells (MSC) contribute to endothelial cell (EC) migration by producing proteases, thereby paving the way into the tissues for the EC. MSC were added to our previously described composite EC-islets as a potential mean to improve their capacity for islet angiogenesis.

Research Design and Methods: Human islets were coated with primary human bone marrow-derived MSC and dermal microvascular EC. The capacity of EC, with or without MSC, to adhere to and grow into human islets was analyzed. The survival and functionality of these composite islets were evaluated in a dynamic perfusion assay, and their capacity for angiogenesis in vitro was assessed in a three-dimensional fibrin gel assay.

Results: EC proliferated after culture in MSC-conditioned medium and MSC improved the EC coverage 3-fold when compared to EC-islets alone. Islet survival in vitro and the functionality of the composite islets after culture were equal to those of control islets. The EC-MSC-islets showed a 2-fold increase in total sprout formation when compared to EC-islets, and vascular sprouts emanating from the EC-MSC-islet surface showed migration of EC into the islets and also into the surrounding matrix, either alone or in concert with MSC.

Conclusions: EC proliferation, sprout formation, and in-growth of EC into the islets were enhanced by MSC. The use of composite EC-MSC-islets may have beneficial effects on revascularization and immune regulation. The technique presented allows for pre-treatment of donor islets with recipient-derived EC and MSC as a means of improving islet engraftment.


Correspondence: Ulrika.Johansson{at}klinimm.uu.se

Key Words: Islets • endothelial cells • mesenchymal stem cells • revascularization and angiogenesis


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Brissova and A. C. Powers
Revascularization of Transplanted Islets: Can It Be Improved?
Diabetes, September 1, 2008; 57(9): 2269 - 2271.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.